Drug Pipeline

PGT121.414.LS Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT06508749
The Tatelo Plus Study		 date change Primary completion moved earlier: 2027-11-05 -> 2027-09-03
2026-05-30 NCT06508749
The Tatelo Plus Study		 date change Completion moved earlier: 2028-04-21 -> 2028-02-18
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06812494 A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal… HIV Recruiting
NCT05719441 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies… Acute HIV Infection Recruiting
Phase 1/2
NCT06508749 The Tatelo Plus Study HIV Recruiting
Phase 1
NCT06517693 Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With… HIV-1 Recruiting
NCT06987318 A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies… HIV-1-infection Not Yet Recruiting
Sponsors Running PGT121.414.LS Trials
National Institute of Allergy and Infectious Diseases (NIAID) (5)
Get alerts when PGT121.414.LS trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free